Literature DB >> 12819324

Anemia management and the delay of chronic renal failure progression.

Jerome Rossert1, Bruno Fouqueray, Jean Jacques Boffa.   

Abstract

Interstitial fibrosis plays a key role in the progression of chronic kidney diseases. Analysis of the biologic effects of erythropoietin and of the pathophysiology of interstitial fibrosis suggest that treatment with epoetin may slow the progression of chronic kidney disease, both by decreasing interstitial fibrosis and by protecting against its consequences. The results of two small prospective studies and of a retrospective one also suggest that treatment with epoetin may have such protective effects.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12819324     DOI： 10.1097/01.asn.0000070079.54912.b6

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


  7 in total

1.  Conservative Management of Chronic Renal Failure.

Authors:  A S Narula; A K Hooda
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease.

Authors:  Shuling Li; Robert N Foley; Allan J Collins
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Effect of Shenkang granules on the progression of chronic renal failure in 5/6 nephrectomized rats.

Authors:  Y U Zhang; Nan Zhou; Hongying Wang; Sicen Wang; Jianyu He
Journal:  Exp Ther Med       Date:  2015-03-24       Impact factor: 2.447

4.  Nutritional and inflammatory status influence darbepoetin dose in pre-dialysis elderly patients.

Authors:  P L Neves; E Morgado; M Faísca; H Carrasqueira; A Baptista; A P Silva
Journal:  Int Urol Nephrol       Date:  2006-12-07       Impact factor: 2.370

Review 5.  Anemia and heart failure.

Authors:  Eileen O'Meara; Clare Murphy; John J V McMurray
Journal:  Curr Heart Fail Rep       Date:  2004-12

Review 6.  Anemia in children with chronic kidney disease.

Authors:  Susan M Koshy; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2007-01-24       Impact factor: 3.714

7.  Anaemia is not a risk factor for progression of acute kidney injury: a retrospective analysis.

Authors:  Jonah Powell-Tuck; Siobhan Crichton; Mario Raimundo; Luigi Camporota; Duncan Wyncoll; Marlies Ostermann
Journal:  Crit Care       Date:  2016-03-08       Impact factor: 9.097
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.